Targeted mydriasis strategies for diabetic retinopathy screening clinics

Eye

Volumn 24, Issue 7, 2010, Pages 1207-1212

  Dervan, E W J ^a   O'Brien, P D ^a   Hobbs, H ^a   Acheson, R ^a   Flitcroft, D I ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

diabetic retinopathy; mydriaisis; screening

Indexed keywords

ADULT; AGED; ARTICLE; CATARACT; DIABETIC RETINOPATHY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYDRIASIS; SCREENING TEST; SEX DIFFERENCE; VISUAL ACUITY;

EID: 77954737749     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.338     Document Type: Article

References (24)

1. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998; 105: 998-1003.
2. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of the diabetic retinopathy study findings. Ophthalmology 1978; 85: 82-106.
3. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985; 103: 1796-1806.
4. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
5. Hansen AB, Hartvig NV, Jensen MS, Borch-Johnsen K, Lund-Andersen H, Larsen M. Diabetic retinopathy screening using digital non-mydriatic fundus photography and automated image analysis. Acta Ophthalmol Scand 2004; 82: 666-672. (Pubitemid 40057775)
6. Massin P, Erginay A, Ben Mehidi A, Vicaut E, Quentel G, Victor Z et al. Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med 2003; 20: 635-641.
7. Facey K, Cummins E, Macpherson K, Morris A, Reay L, Slattery J. Organisation of Services for Diabetic Retinopathy Screening. Health Technology Assessment Report 1. Health Technology Board for Scotland: Glasgow, 2002.
8. Gillow JT, Gray JA. The National Screening Committee review of diabetic retinopathy screening. Eye 2001; 15: 1-2.
9. Goel S, Maharajan P, Chua C, Dong B, Butcher M, Bagga P. Driving ability after pupillary dilatation. Eye 2003; 17: 735-738.
10. Montgomery DM, MacEwan CJ. Pupil dilatation with tropicamide. The effects on acuity, accommodation and refraction. Eye 1989; 3(Part 6): 845-848.
11. Potamitis T, Slade SV, Fitt AW, McLaughlin J, Mallen E, Auld RJ et al. The effect of pupil dilation with tropicamide on vision and driving simulator performance. Eye 2000; 14(Part 3A): 302-306.
12. Wood JM, Garth D, Grounds G, McKay P, Mulvahil A. Pupil dilatation does affect some aspects of daytime driving performance. Br J Ophthalmol 2003; 87: 1387-1390.
13. Schoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology 2001; 108: 563-571.
14. Murgatroyd H, MacEwen C, Leese GP. Patients attitudes towards mydriasis for diabetic eye disease screening. Scott Med J 2006; 51: 35-37.
15. Starck T, Liu Y, Prewett AL, L GC. Comparison of scotopic pupil measurement with slitlamp-based cobalt blue light and infrared video-based system. J Cataract Refract Surg 2002; 28: 1952-1956.
16. Chylack Jr LT, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL et al. The lens opacities classification system III. The longitudinal study of cataract study group. Arch Ophthalmol 1993; 111: 831-836.
17. Murgatroyd H, Ellingford A, Cox A, Binnie M, Ellis JD, MacEwen CJ et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol 2004; 88: 920-924.
18. Hansen AB, Sander B, Larsen M, Kleener J, Borch-Johnsen K, Klein R et al. Screening for diabetic retinopathy using a digital non-mydriatic camera compared with standard 35-mm stereo colour transparencies. Acta Ophthalmol Scand 2004; 82: 656-665.
19. Murgatroyd H, Cox A, Ellingford A, Ellis JD, Macewen CJ, Leese GP. Can we predict which patients are at risk of having an ungradeable digital image for screening for diabetic retinopathy? Eye 2008; 22(3): 344-348.
20. Scanlon PH, Foy C, Malhotra R, Aldington SJ. The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening. Diabetes Care 2005; 28: 2448-2453.
21. Taylor R. Practical community screening for diabetic retinopathy using the mobile retinal camera: report of a 12 centre study. British Diabetic Association Mobile Retinal Screening Group. Diabet Med 1996; 13: 946-952.
22. Pop M, Payette Y, Santoriello E. Comparison of the pupil card and pupillometer in measuring pupil size. J Cataract Refract Surg 2002; 28(2): 283-288.
23. Scanlon PH, Malhotra R, Thomas G, Foy C, Kirkpatrick JN, Lewis-Barned N et al. The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabet Med 2003; 20: 467-474. (Pubitemid 36776007)
24. Higgs ER, Harney BA, Kelleher A, Reckless JP. Detection of diabetic retinopathy in the community using a non-mydriatic camera. Diabet Med 1991; 8: 551-555.